1![Microsoft WordDOCX Microsoft WordDOCX](https://www.pdfsearch.io/img/4649fcc24a1a58fcc313ae60bd267505.jpg) | Add to Reading ListSource URL: securities.stanford.eduLanguage: English - Date: 2016-08-03 18:48:38
|
---|
2![Award ID: CP130020 Project Title: Androgen Receptor N-Terminus Blocker Program for Prostate Cancer Award Mechanism: Company Relocation Award ID: CP130020 Project Title: Androgen Receptor N-Terminus Blocker Program for Prostate Cancer Award Mechanism: Company Relocation](https://www.pdfsearch.io/img/aea3d7168080fa033dba8b54eb9da149.jpg) | Add to Reading ListSource URL: www.cprit.state.tx.usLanguage: English - Date: 2015-03-24 12:30:06
|
---|
3![September 10, 2012 Astex Pharmaceuticals Announces Initiation of HSP90 Inhibitor AT13387 Clinical Trial in Prostate Cancer Patients DUBLIN, Calif., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq: September 10, 2012 Astex Pharmaceuticals Announces Initiation of HSP90 Inhibitor AT13387 Clinical Trial in Prostate Cancer Patients DUBLIN, Calif., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:](https://www.pdfsearch.io/img/331b25ec2003c231793414f599744492.jpg) | Add to Reading ListSource URL: astx.comLanguage: English |
---|
4![Microsoft PowerPointGU Disease Site Schema Flowsheet.pptx Microsoft PowerPointGU Disease Site Schema Flowsheet.pptx](https://www.pdfsearch.io/img/fab9509dd82fd6d7d026104cec67b264.jpg) | Add to Reading ListSource URL: www.ucdenver.eduLanguage: English - Date: 2015-04-07 12:33:12
|
---|
5![R&D Pipeline (October[removed]Global Development (1) Approval / Labeling Revision #Compounds with R&D Pipeline (October[removed]Global Development (1) Approval / Labeling Revision #Compounds with](https://www.pdfsearch.io/img/db2b549e83e888d80c72ee5c996ecc0f.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2014-10-30 05:54:55
|
---|
6![NEWS RELEASE FOR IMMEDIATE RELEASE Tokai Pharmaceuticals to Present at the 34th Annual Cowen Health Care Conference CAMBRIDGE, Mass., February 24, 2014 – Tokai Pharmaceuticals, Inc., a NEWS RELEASE FOR IMMEDIATE RELEASE Tokai Pharmaceuticals to Present at the 34th Annual Cowen Health Care Conference CAMBRIDGE, Mass., February 24, 2014 – Tokai Pharmaceuticals, Inc., a](https://www.pdfsearch.io/img/246b0fd7e0a1dce518999fd49334ea5d.jpg) | Add to Reading ListSource URL: www.tokaipharma.comLanguage: English - Date: 2014-02-24 08:43:32
|
---|
7![NEWS RELEASE FOR IMMEDIATE RELEASE New Phase 2 Clinical Data on Tokai Pharmaceuticals’ Galeterone in Advanced Prostate Cancer to be Presented at 2014 ASCO GU Symposium CAMBRIDGE, Mass., January 9, 2014 – Tokai Pharm NEWS RELEASE FOR IMMEDIATE RELEASE New Phase 2 Clinical Data on Tokai Pharmaceuticals’ Galeterone in Advanced Prostate Cancer to be Presented at 2014 ASCO GU Symposium CAMBRIDGE, Mass., January 9, 2014 – Tokai Pharm](https://www.pdfsearch.io/img/8f234a8e2a943536205e2a39664a5437.jpg) | Add to Reading ListSource URL: www.tokaipharma.comLanguage: English - Date: 2014-01-09 09:29:29
|
---|
8![NEWS RELEASE FOR IMMEDIATE RELEASE Tokai Pharmaceuticals Appoints Karen J. Ferrante, M.D. as Head of R&D and Chief Medical Officer CAMBRIDGE, Mass., April 15, 2014 – Tokai Pharmaceuticals, Inc., a biopharmaceutical NEWS RELEASE FOR IMMEDIATE RELEASE Tokai Pharmaceuticals Appoints Karen J. Ferrante, M.D. as Head of R&D and Chief Medical Officer CAMBRIDGE, Mass., April 15, 2014 – Tokai Pharmaceuticals, Inc., a biopharmaceutical](https://www.pdfsearch.io/img/abbb4d0eab3c493062eacb4b86daf327.jpg) | Add to Reading ListSource URL: www.tokaipharma.comLanguage: English - Date: 2014-04-15 10:19:58
|
---|
9![NEWS RELEASE FOR IMMEDIATE RELEASE Tokai Pharmaceuticals Appoints John McBride as Chief Operating Officer CAMBRIDGE, Mass., February 11, 2014 – Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on devel NEWS RELEASE FOR IMMEDIATE RELEASE Tokai Pharmaceuticals Appoints John McBride as Chief Operating Officer CAMBRIDGE, Mass., February 11, 2014 – Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on devel](https://www.pdfsearch.io/img/db22ec8448955c5dfc31db6ec83daab3.jpg) | Add to Reading ListSource URL: www.tokaipharma.comLanguage: English - Date: 2014-02-11 08:59:12
|
---|
10![NEWS RELEASE FOR IMMEDIATE RELEASE Tokai Pharmaceuticals’ Reformulated Galeterone Demonstrates Robust PSA Reductions in Advanced Prostate Cancer Patients Interim Results from ARMOR2 Phase 2 Study Presented at 2014 ASC NEWS RELEASE FOR IMMEDIATE RELEASE Tokai Pharmaceuticals’ Reformulated Galeterone Demonstrates Robust PSA Reductions in Advanced Prostate Cancer Patients Interim Results from ARMOR2 Phase 2 Study Presented at 2014 ASC](https://www.pdfsearch.io/img/b4ded0bb31280cc5a9e3a4b14a8f917d.jpg) | Add to Reading ListSource URL: www.tokaipharma.comLanguage: English - Date: 2014-01-29 10:23:05
|
---|